Seer Inc Ordinary Shares - Class A SEER 深 沪
等待开盘 07-19 09:30:00 美东时间
2.11
-0.010
-0.47%
华盛通- 最 高2.155
- 今 开2.12
- 成交量 9.66万股
- 最 低 2.095
- 昨 收 2.12
- 总市值 1.24亿
- 52周最高 2.625
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.585
- 委 比 -2.86%
- 总股本 5884.62万
- 历史最高 86.55
- 量 比 0.95
- 振 幅 2.83%
- 历史最低 1.455
- 每 手 1
- 风险率 0.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Mark Cuban Predicts AI Will Create The First Trillionaire And 'It Could Just Be One Dude In The Basement'
Mark Cuban predicts AI will create the world's first trillionaire, citing its potential for innovation and efficiency.
07-05 14:13
Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
Active Ingredient Manufacturing Transfer to the U.S. Complete PRINCETON, N.J., July 1, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharma...
07-01 19:30
Lennox Unveils Elite Series EL18KSLV Side Discharge Heat Pump Designed for Compact Homes
The Lennox Side Discharge Heat Pump is a compact unit designed for efficient, quiet operation. DALLAS, June 23, 2025 /PRNewswire/ -- Lennox Residential HVAC, industry-leader in home comfort ...
06-23 21:03
Chimera Investment to acquire HomeXpress Mortgage
Chimera Investment (NYSE:CIM) to acquire HomeXpress Mortgage from certain affiliates of Seer Capital Management’s credit fund business and certain management sellers. Under the terms of the agreement,...
06-12 18:47
Chimera to Acquire HomeXpress for $120M Plus 2.08M Shares to Expand Loan Origination
Chimera Investment Corporation (NYSE:CIM) ("Chimera") today announced that on June 11, 2025, it entered into a definitive agreement to acquire HomeXpress Mortgage Corp. ("HomeXpress") from certain affiliates of Seer
06-12 18:33
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
Seer, Inc. and Korea University have launched a large-scale proteomics study to identify early cancer biomarkers in young adults. Utilizing Seer's Proteograph ONE Assay and Thermo Fisher's Orbitrap Astral MS, the study will analyze 20,000 plasma samples from cancer patients and healthy individuals across leading Korean institutions. Aims to improve early detection and patient outcomes through advanced proteomics and AI.
06-01 11:00
创新药爆发，百济被低估了？
（转自：乔令财经） 恒瑞医药于5月23日在港股上市，单日上市最高价达到60.5港元，对应市值3995亿，对应市销率为12.76。 如果百济神州也按这个估值...
05-31 19:12
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
SEER Inc. launched its new Proteograph® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument, addressing challenges in large-scale proteomic studies. The advanced workflow enables processing over 1,000 samples weekly, reducing costs by 60% and allowing deep, unbiased proteomic studies at population scale. The suite enhances scalability, reproducibility, and affordability, empowering research in biomarker discovery, d...
05-29 11:00
MrBeast Teases Two More Seasons Of 'Beast Games' After Losing Millions: 'Ideally Don't Lose 8 Figures'
MrBeast announces two more seasons of reality competition "Beast Games" for Prime Video.
05-14 06:08
Earnings Scheduled For May 13, 2025
Companies Reporting Before The Bell • Endeavour Silver (NYSE:EXK) is estimated ...
05-13 16:32
